Analysts Set The Beauty Health Company (NASDAQ:SKIN) Price Target at $28.38

The Beauty Health Company (NASDAQ:SKIN) has been given an average recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $28.38.

A number of equities analysts have commented on SKIN shares. Cowen started coverage on The Beauty Health in a report on Monday, October 4th. They set an “outperform” rating and a $32.00 target price for the company. The Goldman Sachs Group started coverage on The Beauty Health in a report on Thursday, July 1st. They set a “buy” rating and a $31.00 target price for the company. Benchmark increased their target price on The Beauty Health from $18.00 to $25.00 and gave the company a “buy” rating in a report on Wednesday, August 11th. DA Davidson increased their target price on The Beauty Health from $17.50 to $26.00 and gave the company a “buy” rating in a report on Wednesday, August 11th. Finally, Jefferies Financial Group began coverage on The Beauty Health in a research report on Monday, July 19th. They issued a “buy” rating and a $22.00 price target for the company.

NASDAQ SKIN traded up $0.39 during trading hours on Friday, reaching $26.30. The company’s stock had a trading volume of 155,590 shares, compared to its average volume of 1,625,293. The Beauty Health has a 1-year low of $9.71 and a 1-year high of $28.63. The firm has a 50-day moving average price of $24.61.

The Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Tuesday, August 10th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.10. The business had revenue of $66.51 million during the quarter, compared to analyst estimates of $51.30 million. As a group, equities analysts anticipate that The Beauty Health will post 0.15 EPS for the current fiscal year.

A number of institutional investors have recently modified their holdings of SKIN. Alliancebernstein L.P. purchased a new position in The Beauty Health in the second quarter worth approximately $734,000. Nkcfo LLC purchased a new position in shares of The Beauty Health during the second quarter worth $311,000. New York State Common Retirement Fund purchased a new position in shares of The Beauty Health during the second quarter worth $1,036,000. Rhumbline Advisers purchased a new position in shares of The Beauty Health during the second quarter worth $758,000. Finally, Fifth Third Bancorp acquired a new stake in shares of The Beauty Health in the second quarter valued at $29,000. Institutional investors own 63.83% of the company’s stock.

The Beauty Health Company Profile

Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.

Further Reading: What are earnings reports?

Analyst Recommendations for The Beauty Health (NASDAQ:SKIN)

Receive News & Ratings for The Beauty Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Beauty Health and related companies with MarketBeat.com's FREE daily email newsletter.